A Phase I Clinical Trial of Vaccination With KIF20A-derived Peptide in Combination With Gemcitabine For Patients With Advanced Pancreatic Cancer

KIF20A (RAB6KIFL) belongs to the kinesin superfamily of motor proteins, which play critical roles in the trafficking of molecules and organelles during the growth of pancreatic cancer. Immunotherapy using a previously identified epitope peptide for KIF20A is expected to improve clinical outcomes. A...

Descripción completa

Detalles Bibliográficos
Autores principales: Suzuki, Nobuaki, Hazama, Shoichi, Ueno, Tomio, Matsui, Hiroto, Shindo, Yoshitaro, Iida, Michihisa, Yoshimura, Kiyoshi, Yoshino, Shigefumi, Takeda, Kazuyoshi, Oka, Masaaki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2014
Materias:
Clinical Studies
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3868021/
https://www.ncbi.nlm.nih.gov/pubmed/24316554
http://dx.doi.org/10.1097/CJI.0000000000000012

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3868021/
https://www.ncbi.nlm.nih.gov/pubmed/24316554
http://dx.doi.org/10.1097/CJI.0000000000000012

Ejemplares similares